US2006147523A1PendingUtilityA1

Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

Assignee: FERGUSSON ALANPriority: Oct 16, 2002Filed: Feb 27, 2006Published: Jul 6, 2006
Est. expiryOct 16, 2022(expired)· nominal 20-yr term from priority
A61P 3/06A61K 31/56A61K 31/557A61K 31/202A61K 31/575A61P 37/04
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A nutritional supplement composed of phytosterols, anti-oxidants, and other complexes, including essential fatty acids, amino acids, peptides, proline rich polypeptides and digestive enzymes is described. The nutritional supplement may be used by individuals suffering from or at risk of developing immune system diseases; breast cancer, colon and prostate cancer; HIV infection; high cholesterol; or enlarged prostate. In the preferred form, the invention comprises phytosterols and antioxidants, together with essential fatty acids derived from amino acids, short chain peptides, proline rich polypeptides and digestive enzymes, and a microcellulose filler.

Claims

exact text as granted — not AI-modified
1 . A method of modifying blood lipid parameters comprising administering to an individual in need of such treatment an effective amount of a composition comprising: 
 10% to 90% phytosterols;    5% to 85% essential fatty acid complexes; and    5% to 85% antioxidants.    
     
     
         2 . The method according to  claim 1  wherein the composition comprises: 
 29% to 75% phytosterols;    10% to 50% essential fatty acid complexes; and    5% to 50% antioxidants.    
     
     
         3 . The method according to  claim 1  wherein the composition comprises 29% to 75% beta-sitosterol; 10% to 50% essential fatty acid complexes; and 5% to 50% antioxidants.  
     
     
         4 . The method according to  claim 1  wherein the composition comprises 300 mg phytosterols; 50 mg essential fatty acid complexes; 20 mg antioxidants; and 30 mg micro-cellulose filler.  
     
     
         5 . The method according to  claim 1  wherein the total cholesterol to high density lipoprotein ratio of the individual is reduced.  
     
     
         6 . The method according to  claim 1  wherein the low density lipoprotein to high density lipoprotein ratio of the individual is reduced.

Join the waitlist — get patent alerts

Track US2006147523A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.